| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/16/2006 | EP1689441A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689408A1 Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1276471B1 Membrane delivery system |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819840A Use of inhibitors of enzymes with APN and/or DPIV activity and pharmaceutical preparations of said inhibitors for the treatment and prevention of dermatological diseases involving the hyperproliferati |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819826A Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 08/16/2006 | CN1819824A Use of an antioxidant in a dermatological and/or cosmetic composition |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817361A Medicine for treating psoriasis |
| 08/16/2006 | CN1817342A Paeonal gel and its preparing method and quality control |
| 08/16/2006 | CN1269846C Prepn and application of heparin silver |
| 08/16/2006 | CN1269845C Chondroitin sulfate silver and application for treating burn and scald |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/16/2006 | CN1269511C Skin-care Chinese medicine |
| 08/16/2006 | CN1269510C Medicine for treating wound |
| 08/16/2006 | CN1269506C Prepared Chinese traditional medicine for alopecia |
| 08/16/2006 | CN1269499C Medicine efficacious for burn and preparation method |
| 08/16/2006 | CN1269495C Medicinal powder for treating beriberi |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/16/2006 | CN1269476C Composite liposome of vitaminaacid as well as preparation method and application |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091346 Purine derivatives and processes for their preparation |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7090875 Bean extract; fermentation |
| 08/15/2006 | US7090872 comprises acerola seed extract containing quercitrin |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090691 Photodynamic therapy for the treatment of hair loss |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083947A2 Compositions and methods for treating fibrotic disorders |
| 08/10/2006 | WO2006083486A1 Amorphous tacrolimus and preparation thereof |
| 08/10/2006 | WO2006083182A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventing fibrotic disease |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082834A1 Agent for prevention/therapy of disease caused by keratinocyte growth |
| 08/10/2006 | WO2006081616A1 Classes of compounds that interact with integrins |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060178504 Eotaxin: eosinophil chemotactic cytokine |
| 08/10/2006 | US20060178437 Such as systemic lupus erythematosus by administering suberoylanilide hydroxamic acid; histone deacetylase inhibitors |
| 08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/10/2006 | US20060178368 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177526 Pharmaceutical preparation |
| 08/10/2006 | US20060177517 Antiinflammtory agent and antiinflammatory medical material |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | DE202005019443U1 Agent, useful for treating chemical burns caused by hydrofluoric acid, comprises magnesium ion in a hydrophilic medium |
| 08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
| 08/10/2006 | DE102005005274A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
| 08/10/2006 | CA2597146A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease |
| 08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2595786A1 Compositions and methods for treating fibrotic disorders |
| 08/10/2006 | CA2593749A1 Classes of compounds that interact with integrins |
| 08/10/2006 | CA2588480A1 Amorphous tacrolimus and preparation thereof |
| 08/09/2006 | EP1688484A1 Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688161A1 Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
| 08/09/2006 | EP1688145A1 Methods and compositions for treating psoriasis |
| 08/09/2006 | EP1688142A1 Terfenadine carboxylate and the treatment of dermal irritation |
| 08/09/2006 | EP1687327A2 Novel heat shock protein 20-related polypeptides and uses therefor |
| 08/09/2006 | EP1687295A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 08/09/2006 | EP1687030A2 Combination of a dpp iv inhibitor and an anti-obesity or appetite regulating agent |
| 08/09/2006 | EP1687027A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 08/09/2006 | EP1686991A1 Use of piketprofen for the preparation of a pharmaceutical composition to treat rosacea |
| 08/09/2006 | EP1686978A1 Use of idrocilamide for the preparation of a pharmaceutical composition of rosacea |